Skip to main content
OpenTrials
Completed

NCT Number: NCT04005625

Biotherapy Treatment on Features of Microcrystalline Polyarthritis

The study will involve adult patient who had received any biologic agent for microcrystalline disease in western France (Tours, Le Mans, Orléans, Angers, Rennes, Poitiers et Brest) between 01/01/2010 and 31/12/2018.

Investigators will answer retrospectively a questionnaire that covers patient and disease data, biologic agent use, efficacy and adverse events.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Crystal-Induced Arthritis

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, France

About this study

This is a retrospective multicentric study of all patients treated by biologic for microcrystalline disease in France in western France (Tours, Le Mans, Nantes, La Roche sur Yon, Orléans, Angers, Rennes, Poitiers et Brest) between 01/01/2010 and 31/12/2018.

The investigators will collect all clinical (diagnosis of gout CCPD or hydroxyapatitis, tender and swollen joint count), biological (blood results: ESR, CRP, uric acid, synovial analysis), radiological data (X-rays performed and their description) .

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Crystal- induced arthritis
  • Treatment by biologic
  • In western France

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Treatment duration

    Time frame: one year

    Duration of treatment by biologic in days

Secondary outcomes

  1. number of synovitis

    Time frame: inclusion

    number of synovitis on 44

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Features of Microcrystalline Polyarthritis Treated by Biologics and Evolution - FUMBLE Study

Acronym: FUMBLE

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jul 2, 2019
Registry last updated
Sep 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.